SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000012
Filing Date
2020-02-13
Accepted
2020-02-13 16:07:38
Documents
4
Period of Report
2020-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxbodappointment.htm 8-K 44527
2 EXHIBIT 10.1 ex101-bodappointment.htm EX-10.1 15522
3 EXHIBIT 99.1 ex991-bodappointment.htm EX-99.1 12290
4 phasebiologo2a03.jpg GRAPHIC 136353
  Complete submission text file 0001169245-20-000012.txt   256116
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 20610483
SIC: 2834 Pharmaceutical Preparations